Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
SNDX | Syndax Pharmaceuticals Inc | Chief Commercial Officer | $5.69M | Dec 5, 2022 | ||
TPTX | Turning Point Therapeutics, Inc. | SVP & Chief Commercial Officer | Aug 17, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|